What the Wars Taught Us About Blood

An Anzac Day reflection on battlefield medicine, blood banking, and the filter that’s still doing the work

Anzac Day reminds us of service, sacrifice, and the men and women who didn’t come home. It also, less comfortably, reminds us how much of modern medicine was built in field hospitals and casualty clearing stations, paid for by the people we’re commemorating.

Blood transfusion is one of those debts.

Before the war, blood didn’t keep

At the start of the First World War, transfusion was direct. A donor was found, both donor and recipient were prepared, and blood went vein to vein. It worked, sometimes brilliantly, but it was slow. You needed a matched donor on hand. In a casualty clearing station behind the Western Front, that was rarely a luxury you had.

The breakthrough came in 1917. An American army doctor named Captain Oswald Hope Robertson, working with the British forces near Cambrai, set up what we now recognise as the first blood bank. He used sodium citrate to stop blood clotting and added glucose to keep the red cells alive. He stored donated blood in iced ammunition boxes and brought it forward to where the wounded were. Men got transfusions that direct donation could never have reached in time.

That was the start of blood banking. Not in a teaching hospital. In a tent, near artillery, with the wrong equipment.

The Second World War scaled it

Robertson’s work survived the inter-war years mostly as a curiosity. The Second World War turned it into infrastructure.

The British Army Blood Supply Depot at Bristol, established in 1939, became the model for industrial-scale blood collection and distribution. The American Red Cross ran a national plasma program that processed millions of units. Charles Drew’s work on plasma fractionation made it possible to dry plasma, ship it, and reconstitute it in the field. That was the difference between a soldier in North Africa surviving a haemorrhage or not.

By 1945, every part of the modern transfusion service existed in some form: collection, screening, separation, storage, transport, cross-matching, administration. The civilian blood services that grew through the 1950s and 60s, including what eventually became Australian Red Cross Lifeblood, were built directly on that wartime architecture.

Vietnam and the lung problem

The next lesson came in Southeast Asia.

Soldiers receiving large volumes of stored blood after major trauma were developing a peculiar respiratory failure. It wasn’t pneumonia. It wasn’t fluid overload in the usual sense. It looked like ARDS before the term existed, and clinicians called it “shock lung” or “Da Nang lung”. The lungs filled up with debris, oxygenation collapsed, and a non-trivial number of men who’d survived the wound died of the transfusion.

The research that followed, through the late 1960s and 1970s, identified the cause. Stored blood throws off microaggregates. Platelets, fibrin strands and white cell debris, all clumping together as the unit ages. The clumps range from roughly 10 to 160 microns across. The standard giving set filter (170 microns) let almost all of them through. They lodged in the pulmonary microvasculature and triggered the cascade that killed the lungs.

The response was the 40 micron screen filter. A pleated polyester mesh, sized to catch microaggregates while still letting the 8 micron red cell pass. By the early 1980s it was standard kit anywhere rapid or large-volume transfusion was likely.

It is, very directly, a piece of Vietnam-era trauma medicine that walked into the operating theatre and stayed there.

What we know now, and what we use

The microaggregate story turned out to be the start of a longer one. As cell salvage became routine practice through the 1990s and 2000s, we learned that surgical wound blood carries more than clumps. It carries fat globules, particularly in orthopaedic and cardiac cases where bone marrow and adipose tissue are exposed. It carries activated leukocytes that drive complement activation and reperfusion injury. It carries anaphylatoxins like C3a that can produce post-transfusion reactions even from the patient’s own blood.

The 40-micron filter alone wasn’t enough.

This is why we now run the Haemonetics LipiGuard SB (SB1E) routinely on cell salvage cases. It still has the 40-micron screen at its core: the Vietnam-era invention, doing the original job. But it adds a lipid-binding media that captures fat globules, plus a leukocyte-reduction layer that drops white cell counts by around 71%. The hold-up volume is small, roughly 20 mL, so we lose almost no red cells to the filter. Flow is high enough to keep up with rapid reinfusion. It reduces the risk of fat embolic syndrome, complement-mediated lung injury, and the febrile reactions that come from leukocyte breakdown products.

In other words: the same problem the 1970s identified, debris in the lungs, answered with another forty years of materials science and immunology layered on top.

The thread that runs through

When one of our team sets up a cell salvage circuit anywhere in NSW or Victoria this week, the LipiGuard goes in the line as a matter of routine. It costs more than a basic 40-micron filter. It is worth it.

It’s also worth pausing, occasionally, to recognise where the thinking came from.

The blood depot at Cambrai. The Bristol depot. The American Red Cross plasma program. The post-Vietnam research that finally explained why some soldiers were dying after the wound itself was already controlled. Every transfusion in an Australian hospital this week (every cell salvage case, every cardiac bypass, every massive transfusion protocol) runs on a body of knowledge paid for in casualty clearing stations and field hospitals.

Lest we forget.